Plerixafor
- Product NDC
- 65219-284
- 11-digit product format
- 652190284
- Labeler code
- 65219
- Product ID
- 65219-284_ba468eca-fb47-497b-8aed-a1576249ea6a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PLERIXAFOR
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Fresenius Kabi Usa, LLC
- Application
- NDA022311
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2023-06-22
- Substance
- PLERIXAFOR
- Active strength
- 24 mg/1.2mL
- Pharmacologic classes
- Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Plerixafor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PLERIXAFOR | 24 mg/1.2mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | S915P5499N |
| Rxcui | 828700 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65219-284-12 | Plerixafor | 1.2 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 1.2 | | 12 |
| 65219-284-12 | Plerixafor | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65219-284 | PLERIXAFOR INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 11 | Current NDC, 2 package rows | 20231012_5d670cb4-163e-498c-b5fa-c193ea9d55c0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 65219-284-12 | 65219028412 | 1 VIAL, SINGLE-USE in 1 CARTON (65219-284-12) / 1.2 mL in 1 VIAL, SINGLE-USE | 2023-06-22 | No | No | Current |